Research Article Open Access Double-Blind Peer Review

MAPPING THE LANDSCAPE OF RESEARCH ON DISC DEGENERATION AND DEGENERATIVE DISC DISEASE

Xue Mei Wang
Published 25 June 2024
Vol. 1, No. 1 (2024)
pp. 35-44
CC BY 4.0
  1. 1
    Xue Mei Wang
    Graduate School of Changzhi Medical College, Changzhi, 046000, China
    CN

Intervertebral disc degenerative diseases have been increasingly explored, focusing on the balance of synthesis and catabolism, extracellular matrix, growth factors, and inflammatory factors as the underlying causes. Researchers have sought to address these conditions through molecular therapy, cell therapy, and gene therapy. While molecular therapy targets the regulation of growth factors and reduction of inflammatory factors, cell therapy involves the transplantation of exogenous cells and autologous nucleus pulposus cells. Gene therapy, on the other hand, is focused on the inhibition of inflammatory factors through exogenous growth factors. However, these biotherapies face challenges due to the incomplete understanding of disc degeneration's pathogenesis. Advancements in biological therapy depend on further elucidating the mechanisms of intervertebral disc degeneration, making it a crucial area for research exploration. In this study, we conduct a bibliometric analysis to assess the current status and trends in intervertebral disc degeneration research, with a particular focus on nucleus pulposus cells and inflammatory responses. The aim is to identify promising keywords and research directions in this field.

JournalColumbia Journal of Medical Research and Practice
ISSN3065-0631
Volume / IssueVol. 1, No. 1 (2024)
Pages35-44
Published25 June 2024
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Wang, X. (2024). MAPPING THE LANDSCAPE OF RESEARCH ON DISC DEGENERATION AND DEGENERATIVE DISC DISEASE. Columbia Journal of Medical Research and Practice, Vol. 1 No. 1, pp. 35-44

 Submit Your Research to Columbia Journal of Medical Research and Practice

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.